References
- Caviness JN. Myoclonus. Mayo Clin Proc 1996; 71 (7): 679–88
- Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth Heinemann, 1982: 196–248
- Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963; 87: 111
- Pranzatelli MR, Snodgrass SR. The pharmacology of myoclonus. Clin Neuropharmacol 1985; 8(2): 99–130
- Brown P. Myoclonus: a practical guide to drug therapy. CNS Drugs 1995; 3(l): 22–9
- Weiner WJ, Lang AE. Movement disorders: a comprehensive survey. Mount Kisco, NY: Futura, 1989: 293–346
- Hayden MR, Bloch M, Wiggins S. Psychological effects of predictive testing for Huntington's disease. In: Weiner WJ, Lang AE, eds. Behavioral neurology of movement disorders. New York: Raven Press, 1995: 201–10; Advances in Neurology, vol 65
- Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994; 9(5): 493–507
- Weiner, Lang,6 pp 569–97
- Caviness JN, Muenter MD. An unusual cause of recurrent chorea. Mov Disord 1991; 6(4): 355–7